Task: Answer the multiple-choice question.
Question: Which compound exhibits a -33.345% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCNC(=O)c1cc(Br)ccc1Cl
b. CCN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccc(C)c(C)c2)C1=O)C1CCCCC1
Answer: b. CCN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccc(C)c(C)c2)C1=O)C1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccc(C)c(C)c2)C1=O)C1CCCCC1
CCN(C(=O)CN1C(=O)NC(c2ccccc2)(c2ccc(C)c(C)c2)C1=O)C1CCCCC1
N-cyclohexyl-2-[4-(3,4-dimethylphenyl)-2,5-dioxo-4-phenylimidazolidin-1-yl]-N-ethylacetamide